Skip to main content

Table 1 A review of studies of Cy-induced hemorrhagic cystitis in adult or pediatric allogeneic stem cell transplant patients treated successfully with hyperbaric oxygen

From: The utility of hyperbaric oxygen therapy in post-transplant cyclophosphamide-induced hemorrhagic cystitis: a case report and review of the literature

Study identifier

Study design

Inclusion criteria/study groups

Number of patients

Median age (year)

Gender (male: female)

Cyclophosphamide dose

Acute GVHD percentage

Infection percentage

Response rate (%)

K. Hattori et al. [11]

Case report

HC after allogeneic SCT in children

2

7

2:00

60 mg/kg/day for 2 days, 50 mg/kg/day for 4 days

0

0

100

S. Cesaro et al. [12]

Cross sectional

HC in pediatric patients after SCT

38

10.8

4:01

Not disclosed

20

71

84

M. Payandeh et al. [13]

Case report

HC after allogeneic SCT in AML patient

1

40

1:00

Not disclosed

100

0

100

  1. In all reported cases, cyclophosphamide (Cy) was used as part of the conditioning regimen, not as post-transplantation Cy (PTCy). HC hemorrhagic cystitis, SCT stem cell transplant, AML acute myeloid leukemia, GVHD graft-versus-host disease